ORGANOGENESIS HLDGSORGANOGENESIS HLDGSORGANOGENESIS HLDGS

ORGANOGENESIS HLDGS

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.02EUR
Revenue estimate
‪93.65 M‬EUR
Market capitalization
‪302.20 M‬EUR
‪4.48 M‬EUR
‪392.43 M‬EUR
‪77.29 M‬
Beta (1Y)
0.93

About Organogenesis Holdings Inc.

CEO
Gary S. Gillheeney
Headquarters
Canton
Employees (FY)
862
Founded
1985
FIGI
BBG00NN98CK7
Organogenesis Holdings, Inc. is a regenerative medical company, which engages in the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ORGANOGENESIS HLDGS stocks are traded under the ticker 2PQ.
ORGANOGENESIS HLDGS is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
2PQ earnings for the last quarter are 0.03 EUR per share, whereas the estimation was 0.01 EUR resulting in a 223.02% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about ORGANOGENESIS HLDGS earnings.
ORGANOGENESIS HLDGS revenue for the last quarter amounts to ‪102.67 M‬ EUR despite the estimated figure of ‪105.41 M‬ EUR. In the next quarter revenue is expected to reach ‪98.81 M‬ EUR.
Yes, you can track ORGANOGENESIS HLDGS financials in yearly and quarterly reports right on TradingView.
2PQ net income for the last quarter is ‪−514.61 K‬ EUR, while the quarter before that showed ‪3.00 M‬ EUR of net income which accounts for −117.18% change. Track more ORGANOGENESIS HLDGS financial stats to get the full picture.
No, 2PQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2PQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORGANOGENESIS HLDGS stock right from TradingView charts — choose your broker and connect to your account.
2PQ reached its all-time high on May 3, 2021 with the price of 21.00 EUR, and its all-time low was 1.64 EUR and was reached on Apr 26, 2023.
See other stocks reaching their highest and lowest prices.
As of May 1, 2024, the company has 862.00 employees. See our rating of the largest employees — is ORGANOGENESIS HLDGS on this list?
We've gathered analysts' opinions on ORGANOGENESIS HLDGS future price: according to them, 2PQ price has a max estimate of 5.49 EUR and a min estimate of 3.20 EUR. Read a more detailed ORGANOGENESIS HLDGS forecast: see what analysts think of ORGANOGENESIS HLDGS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORGANOGENESIS HLDGS EBITDA is ‪35.95 M‬ EUR, and current EBITDA margin is 9.18%. See more stats in ORGANOGENESIS HLDGS financial statements.